EUVIMEDEUVIMED entdecken
Crossref

Bioactive ROS-responsive nanotherapeutics attenuate intermittent hypoxia-induced cognitive impairment via NRF2/KEAP1/HO-1 signaling

Yinpei Huang, Hailun Xie, Lian Liu, Heng Zhao, Bing Li, Feng Zhang

Neurochemistry International · 2025-09 · 188 · 105997

DOI: 10.1016/j.neuint.2025.105997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemistry International, 2025-09. Verfasst von Yinpei Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head & Neck Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Electroni…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Cognitive Dysfunction, Kelch-Like ECH-Associated Protein 1, Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obstructive sleep apnea (OSA) is characterized by chronic intermittent hypoxia (IH), which induces oxidative stress and neuronal apoptosis, ultimately leading to progressive cognitive impairment. This study investigated the neuroprotective potential of a reactive oxygen species (ROS)-responsive nanotherapeutic, namely TPCD nanoparticles (TPCD NP), synthesized through the conjugation of Tempol and phenylboronic acid pinacol ester to β-cyclodextrin, in both in vivo and in vitro models. In rats, intravenous administration of TPCD NP improved memory performance as assessed by the Morris water maze test, and preserved hippocampal neuronal morphology. TPCD NP significantly reduced intracellular ROS content and malondialdehyde (MDA) levels while restoring antioxidant capacity, including superoxide dismutase (SOD) and glutathione (GSH). Apoptosis was attenuated, as evidenced by the downregulation of Bax and cleaved caspase-3, and the upregulation of Bcl-2 expression. Mechanistically, TPCD NP enhanced the nuclear translocation of nuclear factor erythroid 2-related factor 2 (NRF2), suppressed Kelch-like ECH-associated protein 1 (KEAP1), and increased heme oxygenase-1 (HO-1) expression. The protective effects were abolished by ML385, a selective NRF2 inhibitor, confirming the essential role of NRF2 activation in mediating the antioxidant and anti-apoptotic effects of TPCD NP. In conclusion, TPCD NP attenuates oxidative stress and apoptosis induced by IH in the hippocampus by activating the NRF2/KEAP1/HO-1 pathway. These findings highlight TPCD NP as a promising therapeutic strategy for OSA-associated neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Cognitive DysfunctionKelch-Like ECH-Associated Protein 1NanoparticlesReactive Oxygen SpeciesHypoxiaAnimalsRatsMaleSignal TransductionRats, Sprague-DawleyOxidative StressNeuroprotective AgentsHeme Oxygenase-1Heme Oxygenase (Decyclizing)

Stichwörter der Autor:innen

Intermittent hypoxiaNRF2/KEAP1/HO-1 pathwayNanoparticle therapyNeuroprotectionObstructive sleep apneaOxidative stress

Substanzen

NF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1Nfe2l2 protein, ratKEAP1 protein, ratReactive Oxygen SpeciesHmox1 protein, ratNeuroprotective AgentsHeme Oxygenase-1Heme Oxygenase (Decyclizing)

Autor:innen und Institutionen

  • Department of Otolaryngology, Head & Neck Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Electronic address: huangyinpei@outlook.com.
  • Department of Pathology, Southwest Hospital, Army Medical University, Chongqing, 400038, China. Electronic address: helenxie98@163.com.
  • Department of Otolaryngology, Zigong Fourth People's Hospital, Zigong, Sichuan, 643000, China. Electronic address: 34735984@qq.com.
  • Department of Otolaryngology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorder…
  • Department of Otolaryngology, Head & Neck Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Electronic address: 1390658110@qq.com.

Zitieren

APA

Huang, Y., Xie, H., Liu, L., Zhao, H., Li, B., & Zhang, F. (2025). Bioactive ROS-responsive nanotherapeutics attenuate intermittent hypoxia-induced cognitive impairment via NRF2/KEAP1/HO-1 signaling. Neurochemistry International, 188, 105997. https://doi.org/10.1016/j.neuint.2025.105997

Vancouver

Huang Y, Xie H, Liu L, Zhao H, Li B, Zhang F. Bioactive ROS-responsive nanotherapeutics attenuate intermittent hypoxia-induced cognitive impairment via NRF2/KEAP1/HO-1 signaling. Neurochemistry International. 2025;188:105997. doi:10.1016/j.neuint.2025.105997

BibTeX
@article{Huang2025,
  author = {Huang, Yinpei and Xie, Hailun and Liu, Lian and Zhao, Heng and Li, Bing and Zhang, Feng},
  title = {Bioactive ROS-responsive nanotherapeutics attenuate intermittent hypoxia-induced cognitive impairment via NRF2/KEAP1/HO-1 signaling},
  journal = {Neurochemistry International},
  year = {2025},
  volume = {188},
  pages = {105997},
  doi = {10.1016/j.neuint.2025.105997}
}
Kostenlos starten →